Background Risk of coronary heart disease (CHD) mortality associated with diabetes is high and it is unclear to what extent the high mortality is due to modifiable risk factors. To explore this, mortality and predictors of CHD death are compared in a large cohort of black and white men with diabetes.
risk among people with diabetes. Hypothetical explanations run the gamut from differences in environmental (especially dietary) exposure to ethnicity-related population genetic differences in susceptibility among people with diabetes.
This study explored this issue in the more than 4000 men with diabetes among the men screened for the Multiple Risk Factor Intervention Trial (MRFIT). As previously reported, in this large cohort, mortality and end-stage renal disease (ESRD) risks were significantly higher for those with diabetes compared to those without diabetes. 4 -6 With the large number of deaths among men with diabetes in the MRFIT cohort, it is possible to compare mortality patterns for black and white men with diabetes and the influence of major risk factor findings at baseline on CHD mortality for these two ethnic groups.
Recruitment for MRFIT took place between 1973 and 1975. To recruit the 12 866 trial participants, 361 662 men aged 35-57 years were screened at 22 centres in 18 US cities. Participation was on a voluntary basis: screening was offered to men at work sites and in communities. Details on the screening procedure have been published. 7 The initial screening visit aimed to rapidly identify CHD risk status and exclusion criteria, hence it involved few measurements. Following consent, name, age, and social security number of participants were recorded. Sitting blood pressure was measured by trained observers using a mercury sphygmomanometer according to a standard protocol. Three readings were taken; first and fifth Korotkoff sounds were recorded as systolic blood pressure (SBP) and diastolic blood pressure (DBP). 8 The average of the last two readings was used for analyses. Blood was collected for serum cholesterol measurement, which was done at one of 14 laboratories under the supervision of the MRFIT Central Laboratory and the Lipid Standardization Laboratory of the Centers for Disease Control in Atlanta, Georgia. 9 Information was collected on current smoking habit, use of medication for diabetes, and previous hospitalization of 5=2 weeks for heart attack. Men with diabetes or a previous hospitalization for a heart attack were not eligible for the trial.
Participants were asked to identify themselves as American Indian, Asian, Black, Hispanic, White, or of other ethnicity. Income data were obtained by matching participant zip code of residence with data from the 1980 US population census. Median family income reported in 1979 for blacks and for whites in a given zip code area was used in the analysis. No other data on risk factors were collected at this initial screening visit.
Vital status of the cohort has been ascertained through the National Death Index, and prior to 1979 through the US Social Security Administration. Death ascertainment procedures and their validation have been published. 10 Death certificates were coded centrally for underlying cause of death according to the International Classification of Diseases and Causes of Death, Ninth Revision (ICD-9).
11 Coronary heart disease (CHD) was defined as codes 410-414 or 429.2; stroke as codes 430-438; and total cardiovascular disease deaths as codes 390-459. Death from diabetes was defined as code 250; death from renal disease and the outcome all cause ESRD, defined as either treatment for ESRD, as determined by entry into the national ESRD registry, or death from renal disease, was defined as in previous reports. 6 '
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Of 361 662 men initially screened, 5625 reported taking medication for diabetes. Of these, 4546 identified themselves as white, 745 as black, and 334 as of other ethnicity; 43 (5.8%) black men and 312 (6.9%) white men who reported previous hospitalization of 2 weeks or more for heart attack are excluded from these analyses. Results are given for 3997 white and 610 black men who reported taking medication for diabetes with no history of hospitalization for heart attack and with complete baseline data.
Analysis
Stratified analysis of variance and Mantel Haenszel x 2 statistics were used to compare baseline characteristics of black and white men. Mortality is given as age-adjusted rate per 10 000 person years. Age adjustment was by the direct method using the age distribution of all men screened. Black/white relative risk (RR) of dying from CHD was estimated with a Cox proportional hazards regression model 13 with stratification by screening centre and with covariates corresponding to age, income, serum cholesterol, blood pressure and cigarette smoking status. Cox regression was also used to compare the relationship of baseline risk factors with CHD mortality in black and white men and to assess whether these relationships differed by race. The latter analysis was carried out by including cross-product terms between race and each risk factor in the regression model.
Results

Baseline characteristics of black and white diabetic men
As shown in Table 1 , age, serum cholesterol, and SBP were not significantly different between black and white diabetic men; DBP was higher for blacks (P < 0.001). Percentage of cigarette smokers was also higher for blacks than whites (P < 0.001); black smokers reported using fewer cigarettes/day than whites (18 versus 28, P < 0.001). On average, blacks had lower median income than whites. Table 2 gives 16-year mortality data by cause for black and white men with diabetes, including numbers of deaths and black/white (B/W) adjusted RR. Overall, all cause mortality was similar for black and white men with diabetes-adjusted RR was 0.94 (95% CI : 0.79-1.11). The difference between the age-adjusted and fully-adjusted RR for all cause mortality (1.19 versus 0.94) was largely due to adjustment for income, which was significantly lower among black compared to white men. Only rates for CHD, by far the single largest specific cause of death for both blacks and whites (31% and 44% of all deaths respectively), differed significantly between blacks and whites after adjustment for other risk factors RR = 0.71 (P = 0.02). like all cause mortality, the difference between the age-adjusted and fully-adjusted RR for CHD (0.90 versus 0.71) was largely due to adjustment for income. Adjustment for age and income alone resulted in an adjusted RR of 0.75 (95% CI: 0.56-1.00). Since black smokers reported smoking fewer cigarettes per day than white smokers, this was considered as a possible reason for the lower risk of CHD for blacks compared to whites. However, in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY an analysis adjusting for dgarettes per day instead of smoking status (smoker versus non-smoker), the RR for CHD was similar (RR = 0.75; P = 0.05).
Sixteen-year mortality by cause
Mortality for stroke was higher for blacks, but not significantly so. For all cardiovascular diseases, the adjusted RR was 0.88 (P = 0.31). This higher RR for cardiovascular disease than CHD was accounted for only in part by the higher stroke death rate for blacks than whites. For blacks, two other cardiovascular disease causes of death were reported disproportionately compared to whites, i.e. hypertensive heart disease (1CD-9 402), 9 deaths in blacks and 10 in whites, and cardiac dysrhythmias (ICD-9 427), 9 deaths in blacks and 17 in whites. In blacks, these 18 deaths were 16.1 % of all cardiovascular disease deaths, whereas in whites these 26 deaths accounted for only 3.6% of all cardiovascular disease deaths.
Mortality from renal disease was non-significantly higher among black than whites (adjusted RR = 1.75; P = 0.40); however, like other cardiovascular disease causes, far fewer men died from this cause as compared to CHD. For the outcome, treatment for ESRD or death from renal disease, there were 26 events among black men with diabetes and 97 events among white men with diabetes. The age-adjusted RR was 2.06 (P = 0.002); the fully adjusted RR was 1.43 (P = 0.20). Table 3 summarizes CHD and all cause mortality for black and white men with diabetes by age at screening. No systematic pattern was evident for black and white mortality differences. The P-value corresponding to the interaction between age and race was 0.49 for both all cause and CHD mortality.
Baseline risk factors and 16-year CHD mortality
In univariate analyses, for both black and white men with diabetes, risk factor status at baseline was associated with 16-year CHD death rates (Table 4) . Serum cholesterol s»6.2 mmol/1 (240 rng/dl), high blood pressure, and smoking were all associated with substantial and similar increases in risk of death from CHD for blacks and whites-from 30% to 80% for blacks and from 40% to 90% for whites. Proportional hazards regression coefficients for the association of serum cholesterol, blood pressure, and smoking with mortality from CHD did not differ significantly for black and white men with diabetes (P = 0.91, 0.73, and 0.49, respectively, for serum cholesterol, SBP, and cigarette smoking status). Relative risk estimates indicate that the sizable excess risks of CHD mortality associated with higher baseline level of serum cholesterol or SBP, or with being a smoker were of the same magnitude in black and white men with diabetes, e.g. 17% and 13% for a 1 mmol/1 (40 mg/dl) higher serum cholesterol, 46% and 39% for a 20 mmHg higher SBP, and 26% and 49% for being a smoker (data not shown).
Discussion
The main findings of this study are that for both black and white men with diabetes CHD is the leading cause of death, accounting respectively for 31 % and 44% of all deaths, with an adjusted RR for blacks versus whites of 0.71. As previously reported for this cohort, 4 RR of cardiovascular disease death for men with diabetes as compared to those without diabetes is more than twofold greater in both ethnic groups. Given the high mortality rates for men with diabetes, this RR for men with diabetes compared to those without diabetes corresponds to a substantial absolute excess CHD risk for both blacks and whites. High serum cholesterol, high BP, and smoking are the major risk factors for death from CHD in both ethnic groups. Their high prevalence in men with diabetes of both ethnicities indicates extensive need and potential for prevention of CHD through risk faaor control.
The MRFIT provides data on CHD mortality for the largest group of blacks with diabetes ever prospectively followed; comparison is made with a cohort of white men with diabetes living in the same cities and participating in the same screening programme. Although participation in the study was on a voluntary basis, major selection biases are improbable. Previously reported results comparing men with and without diabetes 4 are concordant with those reported for representative samples of the white and black US population: diabetes prevalence increases with age in both ethnic groups, and is higher in blacks at every age. Furthermore the cardiovascular risk faaor profile observed for black and white men with diabetes is comparable with available information, e.g. higher prevalence of hypertension and lower prevalence of heavy smoking among blacks.
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In two smaller cohorts,' 9 • 20 one a national sample,' 9 a relationship was estimated of baseline diabetes to risk of death from cardiovascular disease and all causes similar to that previously reported from this cohort. 4 Coronary heart disease mortality rates were lower in black men with diabetes than their white counterparts; a similar finding has been reported in other, but not all, studies in people without diabetes. 21 The lower risk for blacks compared to whites was only significant after adjustment for income. This lower risk for blacks compared to whites for both CHD and all cause mortality after adjustment for socioeconomic position is consistent with data from the National Longitudinal Mortality Study. 22 The important role of income as a prediaor of all cause and cause-specific mortality has been previously reported for black and white men in the MRFIT cohort. 23 ' 24 Given well known limitations in death certificate data, caution is needed in interpreting this lower risk of CHD among black as compared to white men with diabetes. In particular when US blacks and whites are compared, artifaaual differences in mortality may result from differences in reporting. In our study, two causes of death, hypertensive heart disease and cardiac dysrhythmias (ICD-9 402 and 427), were reported as underlying causes of death with much higher relative frequency for blacks than whites. The latter cause of death is a non-etiologic one, and the former has been questioned as a valid cause of death distina from hypertensive and atherosclerotic coronary heart disease. A possible role of seleaive mortality, i.e. competing risk, also needs consideration. Compared to whites, blacks have a higher incidence of ESRD, and this is especially apparent in people with diabetes and hypertension. 25 " 28 Mortality from ESRD in blacks may selectively compete with CUD, removing those at high risk for CHD mortality. However, there were only four deaths among blacks from ESRD in this cohort, therefore competing risk is an unlikely explanation for the observed blackwhite difference in CHD mortality. On the other hand, the finding of a lower mortality from CHD in blacks with diabetes in this study is concordant with results of studies reporting a lower incidence of CHD in black than in white men. 21 ' 29 The MRFIT findings on baseline cardiovascular risk factors were similar for the two ethnic groups; if anything blacks with diabetes had a somewhat more adverse pattern than whites (higher DBP and higher prevalence of cigarette smoking). Effects of these risk factors, as judged from the regression coefficients, were not significantly different in black and white men with diabetes. Thus, these major risk factors, measured only once at baseline, apparently do not account for the lower CHD risk in black than white men with diabetes, although rarity of heavy smoking among blacks may have played a role. Other factors, not measured in the study, might also have played a role: e.g. a blackwhite difference in other lipid and lipoprotein levels, with a more favourable pattern in blacks, has been reported among individuals without diabetes as well as those with diabetes. 29 " 33 In regard to diabetes, two variants of non insulin-dependent diabetes have been described in black Americans: with and without insulin resistance. Higher high density lipoprotein (HDL) cholesterol, lower low density lipoprotein (LDL) cholesterol, and lower triglycerides characterize the insulin sensitive type which, according to some reports, is prevalent among blacks. 34 " 36 This may partly account for the lower CHD mortality recorded in blacks with diabetes. A limitation of our investigation is that data on HDL cholesterol and triglycerides are not available for men screened for the MRFIT, nor are data on Lipoprotein(a), flbrinolytic activity, and coagulation factors, which may also influence risk of CHD.
Another limitation is the definition of our group with diabetes. False-positives are minimized because it consists of men who reported taking medication for diabetes. However, if more blacks than whites, or vice versa, had diet-treated diabetes and/or undiagnosed diabetes, and the men studied (taking medication for diabetes) had a different mortality risk than those not studied, this could bias our findings on the relative mortality difference between blacks and whites.
In conclusion, CHD mortality is high in black and white men with diabetes and the major risk factors have similar adverse effects on CHD risk in both black and white men with diabetes. Thus, there is substantial potential for CHD prevention in both groups through control of high plasma cholesterol, high blood pressure, and smoking. 
